Development of a novel arylalkylpiperazine compound (AM-36) as a hybrid neuroprotective drug

Bevyn Jarrott, Jennifer Kay Callaway, William R Jackson, Philip M Beart

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)261 - 267
Number of pages7
JournalDrug Development Research
Publication statusPublished - 1999

Cite this

@article{5863e9ce62b742c2aeed17750c674d13,
title = "Development of a novel arylalkylpiperazine compound (AM-36) as a hybrid neuroprotective drug",
author = "Bevyn Jarrott and Callaway, {Jennifer Kay} and Jackson, {William R} and Beart, {Philip M}",
year = "1999",
language = "English",
pages = "261 -- 267",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "Wiley-Blackwell",

}

Development of a novel arylalkylpiperazine compound (AM-36) as a hybrid neuroprotective drug. / Jarrott, Bevyn; Callaway, Jennifer Kay; Jackson, William R; Beart, Philip M.

In: Drug Development Research, 1999, p. 261 - 267.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Development of a novel arylalkylpiperazine compound (AM-36) as a hybrid neuroprotective drug

AU - Jarrott, Bevyn

AU - Callaway, Jennifer Kay

AU - Jackson, William R

AU - Beart, Philip M

PY - 1999

Y1 - 1999

M3 - Article

SP - 261

EP - 267

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

ER -